Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecur) (a prospective study).


OBJECTIVES This multicenter prospective study of buserelin acetate (Suprecur) therapy for endometriosis was performed in order to examine pregnancy rates and the recurrence of endometriosis 1 year after the end of intranasal administration. METHODS This study was conducted at 349 institutions, including university hospitals and major hospitals in Japan… (More)


  • Presentations referencing similar topics